INTRODUCTION TO
BIOPHARMACEUTICS &
PHARMACOKINETICS
VI SEMESTER
BIOPHARMACEUTICS
• It is defined as the study of factors influencing rate and amount of drug that reaches the
systemic circulation and use of this information to optimize the therapeutic efficacy of
drug product.
• It is the study of physiochemical properties of a drugs, their dosage form in which
they are administered & route of administration as related to onset, duration and
intensity of drug action.
ADME
• A- Absorption
• D- Distribution
• M- Metabolism/Biotransformation
• E- Exertion/Elimination
ABSORPTION
• Movement of drug from its site of administration to systemic-circulation is called as
Absorption.
• Movement of drug in bloodstream.
• Unchanged form to systemic circulation.
DISTRIBUTION
• It is the movement of drug from one compartment to other ( generally blood and other
extravascular tissues) is referred to as distribution.
METABOLISM/BIOTRANSFORMTION
• It is the on version of drug from one form to another via various enzymatic actions.
• It is also known as metabolism i.e. inactivation of drug to finally ending up in
elimination.
Cytochrome P450
ELIMINATION
• It is defined as the process that tends to remove the drug from the body and terminates its
action.
Elimination= Biotransformation+Excretion
PHARMACOKINETICS
• It is defined as the study of time course of drug ADME & their relationship with its
therapeutic and toxic effect of the drug.
“WHAT THE BODY DOES TO THE DRUG”
PHARMACODYNAMICS
Showing clinical response.
“WHAT DRUG DOES TO THE BODY”
DOSE REGIMEN & BIOAVAILABILITY
• The manner in which dose should be taken.
• Dose size.
• Time interval.
• Bioavailability- It is the rate and extent of drug that reaches systemic circulation after
first pass metabolism